ADVERSE DRUG REACTIONS (ADRS): FACTORS AND ROLE OF PHARMACIST IN THEIR PREVENTION
AbstractAdverse drug reactions (ADRs) are the undesirable effects of drugs even when administered in daily normal doses. It has been seen that ADRs may arise even after single administration of drug(s), however, long term therapies are more prone to ADRs. Currently it has become a burning issue all around the world and connected with financial expansion owing to hospitalization. Pharmacists are the custodians of drugs especially clinical pharmacists play a vital role in preventing the risks of ADRs. This review deals with the factors leading to possible ADRs, its prevention and the role of pharmacist in management of ADRs.
Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA. 1975;234(12):1236–41.
BA B. Development and regulation of drugs. In: Katzung BG. Ed. Basic and clinical pharmacology. 10th edn. lange Medical Books/McGraw-Hill, New York. 2007.
Rao PGM, Archana B, Jose J. Implementation and results of an adverse drug reaction reporting programme at an Indian teaching hospital. Indian J Pharmacol 2006;38(4):293–4.
Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci 2011;16(1):16–25.
Rabbur RSM, Emmerton L. An introduction to adverse drug reaction reporting systems in different countries. Int J Pharm Pract 2005;13(1):91–100.
Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000;22(2):161–8.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.
Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag 2005;1(3):181–8.
Oberg KC. Adverse drug reactions. Am J Pharm Edu 1999;63(2):199–203.
Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29–34.
Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991;324(6):377–84.
Tripathi K. Essentials of Pharmacology for Dentistry: Jaypee Brothers; 2007.
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998;316(7140):1295–8.
Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992;34(5):377–95.
Udaykumar P. Textbook of pharmacology for dental and allied health sciences. India: Jaypee Brothers; 2007.
deShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA 1997;278(22):1895–906.
Barry PJ, Gallagher P, Ryan C. Inappropriate prescribing in geriatric patients. Curr Psychiatry Rep 2008;10(1):37–43.
Bowman L, Carlstedt BC, Hancock EF, Black CD. Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Saf 1996;5(1):9–18.
Leach S, Roy SS. Adverse drug reactions: an investigation on an acute geriatric ward. Age Ageing 1986;15(4):241–6.
Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J 2013;22(2):83–94.
Ibáñez L, López-Bermejo A, Díaz M, Marcos MV, Casano P, de Zegher F. Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age. J Clin Endocrinol Metab 2009;94(3):1049–52.
Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285(16):2114–20.
Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1999;33(11):1147–53.
Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988;36(12):1092–8.
Zhu B, Liu ZQ, Chen GL, Chen XP, Ou-Yang DS, Wang LS, et al. The distribution and gender difference of CYP3A activity in Chinese subjects. Br J Clin Pharmacol 2003;55(3):264–9.
Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fundam Clin Pharmacol 2002;16(5):343–6.
Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, Zineh I, et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov. 2007;6(11):904–16.
Belle DJ, Singh H. Genetic factors in drug metabolism. Am Fam Physician 2008;77(11):1553–60.
Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, Pichette V. Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos 2008;36(1):124–8.
Carey DL, Day RO, Bowden FJ. Managing HIV. Common drug interactions in HIV medicine. Med J Aust 1996;164(10):605–6.
Kurnik D, Loebstein R, Farfel Z, Ezra D, Halkin H, Olchovsky D. Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland. Medicine (Baltimore) 2004;83(2):107–13.
Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2007;2(1):79–87.
Kim BH, Yi S, Kim J, Lim KS, Kim KP, Lee B, et al. Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea. Clin Ther 2009;31(6):1234–43.
Woo D, Khoury J, Haverbusch MM, Sekar P, Flaherty ML, Kleindorfer DO, et al. Smoking and family history and risk of aneurysmal subarachnoid hemorrhage. Neurology 2009;72(1):69–72.
Scully C. Drug effects on salivary glands: dry mouth. Oral Dis 2003;9(4):165–76.
Bushra R, Aslam N, Khan AY. Food-drug interactions. Oman Med J. 2011;26(2):77–83.
Pearson TF, Pittman DG, Longley JM, Grapes ZT, Vigliotti DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994;51(18):2268–72.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27(6):538.
Egberts TC, Smulders M, de Koning FH, Meyboom RH, Leufkens HG. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 1996;313(7056):530–1.
Fincham JF. An overview of adverse drug reactions. Am pharm 1991;NS31(6):47–52.
Shah S, Shah H, Khaskheli MN, Akhtar J. Adverse drug reactions: clinical assessment of drug induced disease. J Ayub Med Coll Abottabad. 2005;17(1):89–91.
Agrawal A. Medication errors: Prevention using information technology system. Br J Clin Pharmacol 2009;67(6):681-686.
Franklin BD, O’Grady K, Donyai P, Jacklin A, Barber N. The Impact of a closed-loop electronic prescribing errors, administration errors and staff time: a before-and after study. Qual saf health care,2007;16(4):279-84.
Melmon KL. Preventable drug reactions--causes and cures. N Engl J Med 1971;17;284(24):1361–8.
Miller RR. Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974;134(2):219–23.
1. Dietz BL, Oberg KC. Judicious evaluation of adverse drug reactions: inaccurate assessment of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor‐induced muscle injury. Pharmacotherapy 1999;19(2):232–5.
Burnakis TG. Inaccurate assessment of drug-induced thrombocytopenia: reason for concern. Ann Pharmacother 1994;28(6):726–9.
Khalili H, Mohebbi N, Hendoiee N, Keshtkar AA, Dashti-Khavidaki S. Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists' interventional study. BMJ Open 2012;2:e000367.
Major E. The yellow card scheme and the role of pharmacists as reporters. Pharm J 2002;269(7205):25–6.
Shulman JI, Shulman S, Haines AP. The prevention of adverse drug reactions--a potential role for pharmacists in the primary care team? J R Coll Gen Pract 1981;31(228):429–34